IP Library Granted Patent US 9,347,039
Granted Patent B2
US 9,347,039 · App. 13/844,273 · Granted May 24, 2016

Compositions and methods for processing sperm

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,347,039
App. No.
13/844,273
Granted
May 24, 2016
Kind
B2
Abstract

Generally, compositions and methods for handling processed sperm populations including samples that are freshly collected, transported as fresh samples, as well as samples that are frozen and thawed, those sorted into one or more subpopulations, and those that are otherwise processed or handled that impose trauma on the sperm cell. Such trauma can reduce the motility, fertility, viability and overall integrity of the sperm and reduce the sperm's ability to fertilize an egg, grow into a healthy embryo and produce a healthy offspring. The novel compounds described can be added to the sperm cell sample to reduce the traumatic effects of physical stress during mild as well as extensive sperm cell processing, methods of using the compounds in standard sperm processing procedures, the end products made from these methods including sperm and embryos, as well as methods of using those end products in assisted reproductive biology techniques in animals.

Claims (56)

1. A method of sorting a sperm cell sample to form one or more subpopulations comprising the steps of:

a) providing a sperm cell sample in the form of a sperm cell composition;

b) adding vitamin B12 or a vitamin B12 vitamer to the sperm cell composition to form a mixture, wherein the concentration of the vitamin B12 or B12 vitamer is at a final concentration in the sperm cell mixture in the range of 0.01 mg/ml to 1 mg/ml; and

c) processing the sperm cell mixture with two or more processing steps wherein at least one processing step comprises sorting of the sperm cell sample to form one or more subpopulations.

2. The method as claimed in claim 1 , wherein the method further comprises the step of staining the sperm cell composition of step a) before step b).

3. The method as claimed in claim 1 , wherein the one or more subpopulations comprises at least one gender enriched population of X-chromosome bearing or Y-chromosome bearing sperm cells and further comprising freezing the at least one gender enriched population.

4. The method as claimed in claim 1 , wherein the method further comprises the step of freezing the one or more subpopulations.

5. The method as claimed in claim 3 , wherein the method further comprises the step of thawing the at least one gender enriched population of X-chromosome bearing or Y-chromosome bearing sperm cells and using the at least one gender enriched population of X-chromosome bearing or Y chromosome bearing sperm cells with assisted reproductive technologies (ART).

6. The method as claimed in claim 1 , wherein the method further comprises the step of allowing a time period to elapse after the addition of the vitamin B12, or vitamin B12 vitamer, the time period being in the range of about 2 seconds to about 168 hours.

7. The method as claimed in claim 6 , wherein the time period is selected from the group consisting of: about 2 sec to about 3 min; about 3 min to about 15 min; about 15 min to about 1 hr; about 3 seconds to about 3 hours; about 3 hours to about 6 hours; about 1 hr to about 8 hrs; about 6 hours to about 12 hours; about 8 hrs to about 12 hrs; about 12 hours to about 18 hours; about 18 hours to about 24 hours; about 24 hours to about 36 hours; about 36 hours to about 48 hours; about 48 hours to about 60 hours; about 60 hours to about 72 hours; about 72 hrs to about 96 hrs; about 96 hrs to about 120 hrs; about 120 hrs to about 144 hrs; and about 144 hrs to about 168 hrs.

8. The method as claimed in claim 1 , wherein the processing steps are selected from the group of: holding; transporting; buffering; chilling; warming; staining; diluting; concentrating; exciting with a laser; electronic charging; deflecting; ablating; collecting; shaking; oscillating; magnetically separating; oxygenating; labeling; precipitating; centrifuging; resuspending; mixing; dialyzing; cryostabilizing; freezing; thawing; vitrifying; culturing; inseminating; microinjecting; microfluidic processing; microchip processing; jet and air processing; and flow cytometry processing.

9. The method as claimed in claim 1 , wherein the concentration of the vitamin B12 or vitamin B12 vitamer in the sperm cell mixture is selected from the group consisting of 0.01 mg/ml, 0.05 mg/ml, 0.15 mg/ml, 0.25 mg/ml, 0.3 mg/ml, 0.35 mg/ml, 0.40 mg/ml, 0.45 mg/ml and 0.5 mg/ml.

10. The method as claimed in claim 1 , wherein the method further comprises the step of adding a buffer, a media and/or an extender to the sperm cell sample wherein the buffer, media and/or extender is in a pH range of 5.5 to 7.8.

11. The method as claimed in claim 10 , wherein the pH is selected from the group consisting of 5.5; 5.6; 5.7; 5.8; 5.9; 6.0; 6.1; 6.2; 6.3; 6.4; 6.5; 6.6; 6.7; 6.8; 6.9; 7.0; 7.1; 7.2; 7.3; 7.4; 7.5; 7.6; 7.7; and 7.8.

12. The method as claimed in claim 1 , wherein at least one of the processing steps is carried out within a temperature range selected from the group consisting of about 5° C. to about 15° C.; about 15° C. to about 20° C.; about 20° C. to about 25° C.; about 25° C. to about 30° C.; about 30° C. to about 35° C.; about 35° C. to about 40° C. and about 40° C. to about 45° C.

13. The method as claimed in claim 1 , wherein the sperm cell sample is a frozen thawed sperm cell sample.

14. The method as claimed in 1 , wherein the concentration of the vitamin B12, or vitamin B12 vitamer in the sperm cell mixture, is selected from the group consisting of: 0.01 to 0.25 mg/ml, 0.1 to 0.5 mg/ml, 0.05 to 0.1 mg/ml, 0.05 to 0.5 mg/ml, 0.05 to 1.0 mg/ml, 0.1 to 0.25 mg/ml; 0.1 to 0.5 mg/ml; 0.1 to 1 mg/ml; 0.15 to 0.45 mg/ml; 0.15 to 0.5 mg/ml; 0.25 to 0.35 mg/ml; 0.25 to 0.5 mg/ml; 0.25 to 1 mg/ml; 0.35 to 0.5 mg/ml; 0.35 to 1 mg/ml; and 0.5 to 1 mg/ml.

15. The method of 1 , wherein the concentration of the vitamin B12, or vitamin B12 vitamer, in the sperm cell mixture, is in the range of 0.05 to 0.5 mg/ml in the sperm cell composition.

16. The method of claim 15 , wherein the concentration of the vitamin B12, or vitamin B12 vitamer, in the sperm cell mixture, is selected from the group consisting of: 0.05 mg/ml; 0.1 mg/ml; 0.15 mg/ml; 0.25 mg/ml; 0.35 mg/ml; 0.45 mg/ml; and 0.5 mg/ml.

17. The method of claim 16 , wherein the concentration of the vitamin B12, or vitamin B12 vitamer, in the sperm cell mixture, is about 0.15 mg/ml, about 0.25 mg/ml or 0.35 mg/ml in the sperm cell composition.

18. The method as claimed in claim 1 , wherein the sperm cell sample is manually ablated to kill unwanted cell types within the sperm cell suspension.

19. The method as claimed in claim 1 , wherein the vitamin B12, or vitamin B12 vitamer, is added at a concentration in the range of 0.10 mg/ml to 0.25 mg/ml, and further comprising adding AKG, or a derivative of AKG, at a concentration in the range of 0.15 mg/ml to 0.5 mg/ml in the sperm cell composition.

20. The method as claimed in claim 1 , wherein the vitamin B12, or vitamin B12 vitamer, is added at the concentration of 0.25 mg/ml in the sperm cell composition.

21. The method as claimed in claim 1 , further comprising adding AKG, or a derivative of AKG, at a concentration in the range of 0.25 to 0.45 mg/ml in the sperm cell composition.

22. A method of sorting a sperm cell sample comprising the steps of:

a) providing a sperm cell sample in the form of a sperm cell composition;

b) staining the sperm cell composition with a first media; and

c) sorting the stained sperm cell composition from step b) to form at least one subpopulation contained in

wherein at least one of the first media or the second media contains vitamin B12 or a vitamin B12 vitamer, at a final concentration in the range of 0.01 mg/ml to 1 mg/ml.

23. The method of claim 22 , further comprising the step of freezing the at least one subpopulation in a third media.

24. The method as claimed in claim 22 , wherein the vitamin B12 or, vitamin B12 vitamer, is at a final concentration in the range of 0.1 to 0.25 mg/ml in the sperm cell composition at the time of sorting, and wherein the first media or the second media contains an amount of alpha ketoglutarate (AKG) or a derivatives of AKG, at a final concentration in the range of 0.25 to 0.45 mg/ml in the sperm cell composition at the time of sorting.

25. The method of claim 22 , wherein the concentration of the vitamin B12, or vitamin B12 vitamer, is in the range of 0.05 to 0.5 mg/ml in the sperm cell composition of step b) or the stained sperm cell composition of step c).

26. The method of claim 22 , wherein the concentration of the vitamin B12, or vitamin B12 vitamer, is selected from the group consisting of: 0.05 mg/ml; 0.1 mg/ml; 0.15 mg/ml; 0.25 mg/ml; 0.35 mg/ml; 0.45 mg/ml; and 0.5 mg/ml.

27. The method of claim 23 , wherein the vitamin B12, or vitamin B12 vitamer, is added to: the first media, or the second media, or the third media.

28. The method of claim 23 , wherein the vitamin B12, or vitamin B12 vitamer, is added to: the first media and the second media, or the first and third media, or the second and third media.

29. The method of claim 23 , wherein the vitamin B12, or vitamin B12 vitamer, is added to: the first media, and the second media, and the third media.

30. The method of claim 22 , wherein the sperm cell sample is derived from a human, bovine, swine, ovine, equine, deer, elk, buffalo, canine, feline, chimpanzee, gorilla, or whale, dolphin or other marine mammals.

31. The method as claimed in claim 22 , further comprising the step of using the at least one subpopulation in ART without freezing.

32. The method as claimed in claim 23 , further comprising the steps of thawing the at least one subpopulation and using the at least one subpopulation in ART.

33. A sorted sperm cell composition comprising a sperm cell sample that has been sorted, subjected to one or more processing steps, and contains vitamin B12, or vitamin B12 vitamer, in the range of 0.01 mg/ml to 1 mg/ml.

34. The sorted sperm cell composition of claim 33 , wherein the vitamin B12, or vitamin B12 vitamer, is at a final concentration in the range of 0.1 to 0.25 mg/ml, and wherein the sorted sperm cell composition further comprises alpha ketoglutarate (AKG), or a derivative of AKG, at a final concentration in the range of 0.25 to 0.45 mg/ml.

35. The sorted sperm cell composition of claim 33 , wherein the sperm cell sample has been gender sorted.

36. The sorted sperm cell composition of claim 33 , wherein the sperm cell sample is unfrozen prior to further processing or addition of the vitamin B12, or vitamin B12 vitamer.

37. The sorted sperm cell-composition of claim 33 , wherein the sperm cell sample is frozen and thawed prior to further processing or addition of the vitamin B12, or vitamin B12 vitamer.

38. The sorted sperm cell composition of claim 33 , wherein the sperm cell sample is derived from a human, bovine, swine, ovine, equine, deer, elk, buffalo, canine, feline, chimpanzee, gorilla, or whale, dolphin or other marine mammals.

39. The sorted sperm cell composition of claim 33 , further comprising a cryoprotectant.

40. The sorted sperm cell composition of claim 39 , which is frozen.

41. A method of sorting a sperm cell sample to form one or more subpopulations comprising the steps of:

a) providing a sperm cell sample in the form of a sperm cell composition;

b) processing the sperm cell composition with one or more processing steps wherein the one or more processing steps comprises sorting the sperm cell composition into one or more subpopulations; and

c) adding vitamin B12 or a vitamin B12 vitamer to the one or more subpopulations to form one or more subpopulation mixtures wherein the vitamin B12 or vitamin B12 vitamer is at a final concentration range of 0.01 mg/ml to 1 mg/ml.

42. The method as claimed in claim 41 , wherein the concentration of the vitamin B12 or vitamin B12 vitamer in the one or more subpopulation mixtures is selected from the group consisting of 0.01 mg/ml, 0.05 mg/ml, 0.1 mg/ml, 0.15 mg/ml, 0.25 mg/ml, 0.30 mg/ml, 0.35 mg/ml, 0.40 mg/ml, 0.45 mg/ml and 0.5 mg/ml.

43. The method as claimed in claim 41 , wherein the concentration of the vitamin B12 or vitamin B12 vitamer in the one or more subpopulation mixtures is selected from the group consisting of 0.01 to 0.25 mg/ml, 0.01 to 0.5 mg/ml, 0.05 to 0.5 mg/ml, 0.05 to 0.1 mg/ml, 0.05 to 1.0 mg/ml, 0.1 to 0.25 mg/ml, 0.1 to 0.5 mg/ml, 0.1 to 1 mg/ml, 0.15 to 0.45 mg/ml, 0.15 to 0.5 mg/ml, 0.25 to 0.35 mg/ml, 0.25 to 0.5 mg/ml, 0.25 to 1 mg·ml, 0.35 to 0.5 mg/ml, 0.35 to 1 mg/ml and 0.5 to 1 mg/ml.

44. The method as claimed in claim 41 , wherein the concentration of the vitamin B12 or vitamin B12 vitamer in the one or more subpopulation mixtures is in the range of 0.05 to 0.5 mg/ml.

45. The method as claimed in claim 41 , wherein the concentration of the vitamin B12 or vitamin B12 vitamer in the one or more subpopulation mixtures is selected from the group consisting of 0.05 mg/ml, 0.1 mg/ml, 0.15 mg/ml, 0.25 mg/ml, 0.35 mg/ml, 0.45 mg/ml and 0.5 mg/ml.

46. The method as claimed in claim 45 , wherein the concentration of the vitamin B12 or vitamin B12 vitamer in the one or more subpopulation mixtures is 0.15 mg/ml, 0.25 mg/ml or 0.35 mg/ml.

Assignments (6)
SECURITY INTEREST Recorded Nov 24, 2025
From: INGURAN, LLC
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 073783/0924 →
SECURITY INTEREST Recorded Mar 31, 2021
From: INGURAN, LLC
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 055791/0492 →
RELEASE OF SECURITY INTEREST Recorded Mar 19, 2021
From: BBVA USA, FORMERLY KNOWN AS COMPASS BANK
To: INGURAN, LLC
Reel/Frame 055646/0416 →
SECURITY INTEREST Recorded Mar 24, 2015
From: INGURAN, LLC
To: COMPASS BANK
Reel/Frame 035243/0421 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ADDRESS OF ASSIGNEE PREVIOUSLY RECORDED ON REEL 030034 FRAME 0435. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Aug 20, 2013
From: LENZ, RICHARD; MORENO, JUAN; VISHWANATH, RAMAKRISHNAN
To: INGURAN, LLC
Reel/Frame 031057/0888 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 18, 2013
From: LENZ, RICHARD; MORENO, JUAN; VISHWANATH, RAMAKRISHNAN
To: INGURAN, LLC
Reel/Frame 030034/0435 →